ControversiesChallengesConsensus
}

About Anthony Strzalek

This author has not yet filled in any details.
So far Anthony Strzalek has created 32 blog entries.

CX 2020 LIVE panel considers advances in thoracic care with new developments in TEVAR

2020-06-05T15:07:47+01:00

Ali Azizzadeh (top) chaired the CX 2020 LIVE Industry Symposium, which featured contributions from Hence Verghagen (bottom row left), Richard Gibbs (bottom row left), and Santi Trimarchi (bottom row right)

Benefits of using angulation control in thoracic endovascular aortic repair (TEVAR), an update […]

CX 2020 LIVE panel considers advances in thoracic care with new developments in TEVAR2020-06-05T15:07:47+01:00

CX 2020 LIVE features key registry data on EVAR durability with EXCLUDER Conformable AAA Endoprosthesis

2020-06-02T09:27:26+01:00

Data from three global, real-world registries, GREAT, ExCeL and BSET-CLEVAR, evaluating the Excluder Conformable abdominal aortic aneurysm (AAA) Endoprosthesis with Active Control System, were shared online during the CX 2020 LIVE virtual, vascular conference. Broadcast to a global audience at the conclusion of the second […]

CX 2020 LIVE features key registry data on EVAR durability with EXCLUDER Conformable AAA Endoprosthesis2020-06-02T09:27:26+01:00

CX 2020 LIVE: Vascular Access education and innovation “imperative” during COVID-19 crisis

2020-05-22T16:58:23+01:00


CX 2020 LIVE will consist of 10 live sessions, which will feature audience participation, and run from 16:00 BST/11:00 EDT/17:00 CEST every Tuesday and Thursday, from 26 May until 25 June. Make sure you register now to participate in the CX 2020 LIVE sessions.

Nicholas Inston (Birmingham, UK), co-chair of the Vascular […]

CX 2020 LIVE: Vascular Access education and innovation “imperative” during COVID-19 crisis2020-05-22T16:58:23+01:00

CX 2020 LIVE to flag latest guidelines and stent durability in superficial and deep venous programmes

2020-05-20T12:57:01+01:00

Manj Gohel (Cambridge, UK), who is also a member of the CX Venous Executive Board, welcomes you to CX 2020 LIVE, which will include some of the major highlights from the deep and superficial venous programmes.

A number of recently released “important guidelines” in the superficial venous space will be presented […]

CX 2020 LIVE to flag latest guidelines and stent durability in superficial and deep venous programmes2020-05-20T12:57:01+01:00

CX 2020 LIVE: Durability of EVAR, sac diameter and NICE guidelines take the spotlight in first aortic session

2020-05-18T18:09:13+01:00

World-leading vascular surgeon, Stéphan Haulon (Paris, France), who is also a member of the CX Aortic Executive Board, extols the “high-quality” digital educational programme of CX 2020 LIVE and highlights the “very exciting” thoracic aortic and abdominal aortic consensus sessions that will be chaired by a host of other experts […]

CX 2020 LIVE: Durability of EVAR, sac diameter and NICE guidelines take the spotlight in first aortic session2020-05-18T18:09:13+01:00

COVID-19: No evidence of increased aortic emergencies in Lombardy

2020-05-19T10:33:36+01:00

Roberto Chiesa (Milan, Italy), who was at the frontline of the COVID-19 pandemic in the Lombardy region of Italy, shares his team’s experience in tackling vascular and aortic emergencies during this time.

Chiesa outlines the response in the region to the pandemic, including the creation of new intensive care units (ICUs) […]

COVID-19: No evidence of increased aortic emergencies in Lombardy2020-05-19T10:33:36+01:00

Paclitaxel controversy to headline inaugural CX 2020 LIVE session

2020-05-15T17:41:25+01:00


Join a wealth of experts and faculty from around the world for the very first session of CX 2020 LIVE—the inaugural virtual Charing Cross (CX) Symposium—titled ‘Paclitaxel-coated Device Consensus Update’.

Renowned interventional radiologist Andrew Holden (Auckland, New Zealand), who is a member of the CX Peripheral Arterial Executive Board, welcomes the […]

Paclitaxel controversy to headline inaugural CX 2020 LIVE session2020-05-15T17:41:25+01:00

CX 2020 LIVE: Charing Cross Symposium unveils live, interactive digital event

2020-05-13T17:13:26+01:00

The Charing Cross (CX) Symposium, with its world-class faculty and unique focus on live audience participation, has announced the launch of a not-to-be missed and timely vascular and endovascular education virtual event: CX 2020 LIVE. Mark your calendars for this live digital experience, designed to deliver high-quality vascular education and featuring […]

CX 2020 LIVE: Charing Cross Symposium unveils live, interactive digital event2020-05-13T17:13:26+01:00

Number of vascular surgeons being trained is “woefully inadequate”

2020-03-09T14:43:42+00:00

Sophie Renton (London, UK) moderates a session with Michel Makaroun (Pittsburgh, USA) and Armando Mansilha (Porto, Portugal) where the trio discuss some of the challenges relating to recruitment within the field of vascular surgery.

Makaroun explains that there are two main recruitment pathways into vascular surgery in the USA but notes […]

Number of vascular surgeons being trained is “woefully inadequate”2020-03-09T14:43:42+00:00

CX 2020: What to expect from this year’s Aortic Workshop

2020-03-09T10:48:40+00:00

Kevin Mani (Uppsala, Sweden) chats to BLearning about the upcoming Aortic Workshop at CX 2020 (Charing Cross Symposium; 21–24 April, London, UK), noting how the sessions will give attendees access to experts, the latest technologies and provide a platform for hands-on experience with new devices and imaging technology.

Workshop participants can take this […]

CX 2020: What to expect from this year’s Aortic Workshop2020-03-09T10:48:40+00:00

Michel Makaroun discusses why the CX Symposium is a “special meeting”

2020-03-09T09:09:07+00:00

Roger Greenhalgh (London, UK) speaks to former president of the SVS (2018–2019) Michel Makaroun (Pittsburgh, USA) about the CX Symposium which Makaroun says “always has a special flavour” and is “a special meeting”. Makaroun also touches on some of the similarities and differences between CX and the SVS meeting in […]

Michel Makaroun discusses why the CX Symposium is a “special meeting”2020-03-09T09:09:07+00:00

Long-term partnership helps drive CX Symposium forward

2020-03-06T09:50:48+00:00

Roger Greenhalgh (London, UK) and W L Gore’s Michael Koenke (Flagstaff, USA), take a look back at the history of the Charing Cross Symposium (CX), which began in 1978.

Koenke says that CX is a “special meeting for us”, adding that it is an “opportunity for us to connect with our […]

Long-term partnership helps drive CX Symposium forward2020-03-06T09:50:48+00:00

Scientific level of CX Symposium “very attractive” for attendees

2020-03-06T09:55:51+00:00

Roger Greenhalgh (London, UK) chats with Enrico Ascher (New York, USA) about some of the highlights of the CX Symposium, how it differs to the VEITH symposium in the USA and also how the two complement each other.

Ascher says he is always “totally amazed by the scientific level” of CX, […]

Scientific level of CX Symposium “very attractive” for attendees2020-03-06T09:55:51+00:00

CX 2019: A Latin American perspective in vascular and endovascular surgery

2020-03-02T14:30:44+00:00

Alberto Muñoz (Bogota, Colombia) talks to BLearning at CX 2019 (Charing Cross Symposium; 15–18 April, London, UK) about how the meeting provides a “great opportunity” to update attendees on the latest in vascular and endovascular surgery.

Muñoz goes on to highlight the international flavour of Charing Cross and notes the importance of the […]

CX 2019: A Latin American perspective in vascular and endovascular surgery2020-03-02T14:30:44+00:00

CX 2019: Experts discuss latest findings from the STEP study

2019-11-01T10:14:03+00:00

Roger Greenhalgh (London, UK) is joined by Fiona Rohlffs (Hamburg, Germany), Tilo Kölbel (Hamburg, Germany) and Heinz Jakob (Essen, Germany) to discuss the latest findings of the Stroke from Thoracic Endovascular Procedures (STEP) study which were presented at CX 2019 (Charing Cross Symposium; 15–18 April 2019, London, UK). […]

CX 2019: Experts discuss latest findings from the STEP study2019-11-01T10:14:03+00:00

Type II endoleak with secondary sac expansion remains elusive

2020-01-08T13:00:32+00:00

Leading experts including Robert Morgan (London, UK), Richard McWilliams (Liverpool, UK), Stéphan Haulon (Paris, France), Tilo Kölbel (Hamburg, Germany) and Peter Schneider (Honolulu, USA) discuss the various approaches to correcting endoleak during CX 2018 (Charing Cross Symposium; 24–27 April 2018; London, UK).

Type II endoleak with secondary sac expansion remains elusive2020-01-08T13:00:32+00:00

MDR will be “the most devastating thing to happen to European healthcare since WW2”

2019-09-16T10:41:45+01:00

Speaking at the Charing Cross Symposium 2019, Jeffrey Jump (Nyon, Switzerland), outlines the impact of the Medical Device Regulations (MDR), which he believes will be “the most devastating thing to happen to European healthcare in Europe since World War Two”.

Patients “will bear the brunt of this hardship” says Jump, who […]

MDR will be “the most devastating thing to happen to European healthcare since WW2”2019-09-16T10:41:45+01:00

Intra-arterial calcification poses “one of the biggest challenges” for endovascular therapy

2019-09-06T16:03:07+01:00

Andrew Holden (Auckland, New Zealand) provides perspective on the first results from the Disrupt PAD III observational registry that were presented at the Charing Cross International Symposium 2019. This large registry is designed to evaluate the use of Intravascular Lithotripsy (IVL; Shockwave) in the treatment of calcified arteries beyond the […]

Intra-arterial calcification poses “one of the biggest challenges” for endovascular therapy2019-09-06T16:03:07+01:00

With CoveredSeal, Valiant Navion™ offers physicians the “best of both worlds” for TEVAR procedures

2019-09-06T16:05:44+01:00

Paul Hayes (Cambridge, UK), Frank Arko (Charlotte, USA) and Fabio Verzini (Turin, Italy) discuss the Valiant Navion™ (Medtronic) live thoracic endovascular aortic repair (TEVAR) case at Charing Cross 2019, which demonstrated the use of the new CoveredSeal proximal configuration.

Hayes talks about the accuracy of the device’s deployment around the thoracic […]

With CoveredSeal, Valiant Navion™ offers physicians the “best of both worlds” for TEVAR procedures2019-09-06T16:05:44+01:00

With focal dissection repair, the Tack Endovascular System “returns control to the operator”

2019-09-06T16:08:00+01:00

Andrew Holden (Auckland, New Zealand) and Peter Schneider (San Francisco, USA) discuss the Tack Endovascular System (Intact Vascular) and its impact on below the knee and above the knee procedures at the Charing Cross Symposium 2019. Schneider talks about the “limitations of the current clunky stenting paradigm” and how the […]

With focal dissection repair, the Tack Endovascular System “returns control to the operator”2019-09-06T16:08:00+01:00

Durability of endovascular aneurysm repair and the NICE guidelines

2019-09-06T16:08:53+01:00

A CX 2019 special session highlighted the durability of endovascular aneurysm repair (EVAR) and the implications of the UK National Institute for Health and Care Excellence (NICE) draft aortic aneurysm guidelines. The final publication of these guidelines has been postponed on numerous occasions.

Opening the session, Stéphan Haulon and his team […]

Durability of endovascular aneurysm repair and the NICE guidelines2019-09-06T16:08:53+01:00

Optimising surveillance and reintervention strategy following elective EVAR

2019-09-06T16:09:48+01:00

Roger Greenhalgh (London, UK) interviewed Fiona Rohlffs (Hamburg, Germany), Maarit Venermo (Helsinki, Finland) and David Epstein (Granada, Spain) at the CX Live studio after their ‘Optimising surveillance and reintervention strategy following elective EVAR’ session.

Optimising surveillance and reintervention strategy following elective EVAR2019-09-06T16:09:48+01:00

New APERTO AVF RCT data show DCB reduces restenosis significantly more than high-pressure balloon alone

2019-09-06T16:10:43+01:00

Matteo Tozzi (Varese, Italy) discusses new data from the APERTO AVF study, the first randomised trial in China to compare the safety and efficacy of the APERTO drug-coated balloon (DCB; Cardionovum) with a high-pressure balloon. The trial results for the treatment of failing haemodialysis arteriovenous shunts were presented by Qizhuang […]

New APERTO AVF RCT data show DCB reduces restenosis significantly more than high-pressure balloon alone2019-09-06T16:10:43+01:00

TEVAR performed outside the IFU has “dramatically worse outcomes”

2019-09-06T16:11:31+01:00

Dittmar Boeckler (Heidelberg, Germany) tells CX Live that treating patients with thoracic endovascular aortic repair (TEVAR) outside the instructions for use (IFU) has a dramatic effect on patient outcomes after the procedure. “We observed a significant increase in mortality […] an increased reintervention rate and four times higher endoleak rate,” […]

TEVAR performed outside the IFU has “dramatically worse outcomes”2019-09-06T16:11:31+01:00